These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 26311727)

  • 21. Breast cancer following ovarian cancer in BRCA mutation carriers.
    Gangi A; Cass I; Paik D; Barmparas G; Karlan B; Dang C; Li A; Walsh C; Rimel BJ; Amersi FF
    JAMA Surg; 2014 Dec; 149(12):1306-13. PubMed ID: 25372568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving the Performance of Somatic Mutation Identification by Recovering Circulating Tumor DNA Mutations.
    Fu Y; Jovelet C; Filleron T; Pedrero M; Motté N; Boursin Y; Luo Y; Massard C; Campone M; Levy C; Diéras V; Bachelot T; Garrabey J; Soria JC; Lacroix L; André F; Lefebvre C
    Cancer Res; 2016 Oct; 76(20):5954-5961. PubMed ID: 27535334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatic mutations of mitochondrial genome in early stage breast cancer.
    Wang CY; Wang HW; Yao YG; Kong QP; Zhang YP
    Int J Cancer; 2007 Sep; 121(6):1253-6. PubMed ID: 17514652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 mutations in BRCA1-associated familial breast cancer.
    Schlichtholz B; Bouchind'homme B; Pagés S; Martin E; Liva S; Magdelenat H; Sastre-Garau X; Stoppa-Lyonnet D; Soussi T
    Lancet; 1998 Aug; 352(9128):622. PubMed ID: 9746028
    [No Abstract]   [Full Text] [Related]  

  • 25. [Exploratory study of circulating tumor DNA detection in early breast cancer: an analysis of 75 next-generation sequencing results].
    Zhou B; Xin L; Xu L; Liu YH; Zhang MM; Jing RL; Liang XY; Cao SB
    Zhonghua Wai Ke Za Zhi; 2017 Nov; 55(11):847-852. PubMed ID: 29136733
    [No Abstract]   [Full Text] [Related]  

  • 26. Medullary carcinoma of breast with a novel germline mutation 1123T >G in exon 11 of BRCA1.
    Moattar T; Kausar T; Aban M; Khan S; Pervez S
    J Coll Physicians Surg Pak; 2006 Sep; 16(9):606-7. PubMed ID: 16945238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Features of Circulating DNA Fragmentation in Blood of Healthy Females and Breast Cancer Patients.
    Tamkovich SN; Kirushina NA; Voytsitskiy VE; Tkachuk VA; Laktionov PP
    Adv Exp Med Biol; 2016; 924():47-51. PubMed ID: 27753018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients.
    Taback B; Giuliano AE; Hansen NM; Singer FR; Shu S; Hoon DS
    Cancer Res; 2003 Apr; 63(8):1884-7. PubMed ID: 12702578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The identification of a new mutation in the BRCA2 gene by protein truncation analysis in a Spanish family with hereditary breast cancer].
    Díez O; del Río E; Domènech M; Sanz J; Cortés J; Brunet J; Alonso Mdel C; Baiget M
    Med Clin (Barc); 1999 Feb; 112(5):179-81. PubMed ID: 10091212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ESR1 Mutations in Breast Cancer: Proof-of-Concept Challenges Clinical Action.
    Gu G; Fuqua SA
    Clin Cancer Res; 2016 Mar; 22(5):1034-6. PubMed ID: 26700205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The combination of p53 mutation and neu/erbB-2 amplification is associated with poor survival in node-negative breast cancer.
    Bull SB; Ozcelik H; Pinnaduwage D; Blackstein ME; Sutherland DA; Pritchard KI; Tzontcheva AT; Sidlofsky S; Hanna WM; Qizilbash AH; Tweeddale ME; Fine S; McCready DR; Andrulis IL
    J Clin Oncol; 2004 Jan; 22(1):86-96. PubMed ID: 14701769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracellular DNA in breast cancer: Cell-surface-bound, tumor-derived extracellular DNA in blood of patients with breast cancer and nonmalignant tumors.
    Rykova EY; Laktionov PP; Skvortsova TE; Starikov AV; Kuznetsova NP; Vlassov VV
    Ann N Y Acad Sci; 2004 Jun; 1022():217-20. PubMed ID: 15251963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered WAF1 genes do not play a role in abnormal cell cycle regulation in breast cancers lacking p53 mutations.
    McKenzie KE; Siva A; Maier S; Runnebaum IB; Seshadri R; Sukumar S
    Clin Cancer Res; 1997 Sep; 3(9):1669-73. PubMed ID: 9815858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Initial Dutch results with a presymptomatic DNA tests in familial breast/ovarian carcinoma. Rotterdamse Werkgroep voor Erfelijke Tumoren].
    Klijn JG; Devilee P; van Geel AN; Tilanus-Linthorst MM; Dudok-de Wit C; Meijers-Heijboer EJ
    Ned Tijdschr Geneeskd; 1995 Mar; 139(9):439-45. PubMed ID: 7891765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absence of COSMC gene mutations in breast and colorectal carcinomas.
    Yoo NJ; Kim MS; Lee SH
    APMIS; 2008 Feb; 116(2):154-5. PubMed ID: 18321367
    [No Abstract]   [Full Text] [Related]  

  • 37. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
    Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
    Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Detection of free tumor-related DNA in the serum of breast cancer patients].
    Zhang JJ; Ouyang T; Wan WH; Deng GR
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):609-13. PubMed ID: 18210882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of a novel Alu-mediated BRCA1 exon 13 duplication in Chinese breast cancer patients and implications for genetic testing.
    Yap KP; Ang P; Lim IH; Ho GH; Lee AS
    Clin Genet; 2006 Jul; 70(1):80-2. PubMed ID: 16813611
    [No Abstract]   [Full Text] [Related]  

  • 40. Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid.
    Zhu W; Qin W; Bradley P; Wessel A; Puckett CL; Sauter ER
    Carcinogenesis; 2005 Jan; 26(1):145-52. PubMed ID: 15375011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.